ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

Study Seeks Newly Diagnosed Prostate Cancer Patients

March 26, 2010

In Brief: Julie Vose Was Elected President of the American Society of Clinical Oncology

January 3, 2014

Organ Systems Move, Other Directory Changes

July 7, 1989

DeVita Denies NCI Broke Faith With Communities On CHOP Awards, Says Total Of 30 “Not Absolute”

August 15, 1980

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989